{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:25:38Z","timestamp":1793298338169,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,13]]},"DOI":"10.7759\/cureus.75677","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T01:29:48Z","timestamp":1734139788000},"source":"Crossref","is-referenced-by-count":7,"title":["A Comprehensive Review of Pathophysiological Link Between Non-alcoholic Fatty Liver Disease, Insulin Resistance, and Metabolic Syndrome"],"prefix":"10.7759","author":[{"given":"Eudith","family":"Januario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhivanditha","family":"Rajsundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varda","family":"Nanda Palienkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun V","family":"Bullapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunchandandeep","family":"Singh Brar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punam","family":"Kharel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishal Mohammed","family":"Koyappathodi Machingal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amena","family":"Backosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2005.042200","article-title":"Treatment of non-alcoholic fatty liver disease","volume":"82","author":"Adams LA","year":"2006","unstructured":"Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J. 2006, 82:315-22. 10.1136\/pgmj.2005.042200","journal-title":"Postgrad Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper P","year":"2021","unstructured":"Kasper P, Martin A, Lang S, K\u00fctting F, Goeser T, Demir M, Steffen HM. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021, 110:921-37. 10.1007\/s00392-020-01709-7","journal-title":"Clin Res Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165838","article-title":"Mitochondrial dysfunction in metabolic syndrome","volume":"1866","author":"Prasun P","year":"2020","unstructured":"Prasun P. Mitochondrial dysfunction in metabolic syndrome. Biochim Biophys Acta Mol Basis Dis. 2020, 1866:165838. 10.1016\/j.bbadis.2020.165838","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i37.6777","article-title":"Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction","volume":"23","author":"Pasar\u00edn M","year":"2017","unstructured":"Pasar\u00edn M, Abraldes JG, Liguori E, Kok B, La Mura V. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. World J Gastroenterol. 2017, 23:6777-87. 10.3748\/wjg.v23.i37.6777","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13125","article-title":"Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort","volume":"14","author":"Choe HJ","year":"2023","unstructured":"Choe HJ, Lee H, Lee D, Kwak SH, Koo BK. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort. J Cachexia Sarcopenia Muscle. 2023, 14:260-9. 10.1002\/jcsm.13125","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin resistance: from mechanisms to therapeutic strategies","volume":"46","author":"Lee SH","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022, 46:15-37. 10.4093\/dmj.2021.0280","journal-title":"Diabetes Metab J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes","volume":"46","author":"Kahn SE","year":"2003","unstructured":"Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003, 46:3-19. 10.1007\/s00125-002-1009-0","journal-title":"Diabetologia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen MC","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018, 98:2133-223. 10.1152\/physrev.00063.2017","journal-title":"Physiol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.6.1001","article-title":"Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study","volume":"46","author":"Perseghin G","year":"1997","unstructured":"Perseghin G, Ghosh S, Gerow K, Shulman GI. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes. 1997, 46:1001-9. 10.2337\/diab.46.6.1001","journal-title":"Diabetes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"281","author":"Randle PJ","year":"1963","unstructured":"Randle PJ, Garland PB, Hales CN, Newsholme EA.  The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963, 281:785-9. 10.1016\/S0140-6736(63)91500-9","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.16.10464","article-title":"13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat","volume":"272","author":"Jucker BM","year":"1997","unstructured":"Jucker BM, Rennings AJ, Cline GW, Shulman GI. 13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat. J Biol Chem. 1997, 272:10464-73. 10.1074\/jbc.272.16.10464","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1960.199.2.235","article-title":"Glucose inhibition of fatty acid oxidation by rat diaphragm","volume":"199","author":"SC LI","year":"1960","unstructured":"SC LI, BR J. Glucose inhibition of fatty acid oxidation by rat diaphragm. Am J Physiol. 1960, 199:235-7. 10.1152\/ajplegacy.1960.199.2.235","journal-title":"Am J Physiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.25.2.235","article-title":"Cardiac glucose and fatty acid oxidation in the streptozotocin-induced diabetic spontaneously hypertensive rat","volume":"25","author":"Christe ME","year":"1995","unstructured":"Christe ME, Rodgers RL. Cardiac glucose and fatty acid oxidation in the streptozotocin-induced diabetic spontaneously hypertensive rat. Hypertension. 1995, 25:235-41. 10.1161\/01.hyp.25.2.235","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115686","article-title":"31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus","volume":"89","author":"Rothman DL","year":"1992","unstructured":"Rothman DL, Shulman RG, Shulman GI. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest. 1992, 89:1069-75. 10.1172\/JCI115686","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907223410404","article-title":"Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes","volume":"341","author":"Cline GW","year":"1999","unstructured":"Cline GW, Petersen KF, Krssak M, et al.. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med. 1999, 341:240-6. 10.1056\/NEJM199907223410404","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001253220403","article-title":"Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy","volume":"322","author":"Shulman GI","year":"1990","unstructured":"Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 1990, 322:223-8. 10.1056\/NEJM199001253220403","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(19)67706-9","article-title":"Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance","volume":"266","author":"Marshall S","year":"1991","unstructured":"Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem. 1991, 266:4706-12. 10.1016\/s0021-9258(19)67706-9","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119390","article-title":"Role of the glucosamine pathway in fat-induced insulin resistance","volume":"99","author":"Hawkins M","year":"1997","unstructured":"Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rossetti L. Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest. 1997, 99:2173-82. 10.1172\/JCI119390","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1997.272.6.E1080","article-title":"Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob\/ob mice","volume":"272","author":"Buse MG","year":"1997","unstructured":"Buse MG, Robinson KA, Gettys TW, McMahon EG, Gulve EA. Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob\/ob mice. Am J Physiol. 1997, 272:E1080-8. 10.1152\/ajpendo.1997.272.6.E1080","journal-title":"Am J Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.12.1438","article-title":"Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver","volume":"44","author":"Robinson KA","year":"1995","unstructured":"Robinson KA, Weinstein ML, Lindenmayer GE, Buse MG. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes. 1995, 44:1438-46. 10.2337\/diab.44.12.1438","journal-title":"Diabetes"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwl067","article-title":"Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats","volume":"17","author":"Akimoto Y","year":"2007","unstructured":"Akimoto Y, Hart GW, Wells L, et al.. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology. 2007, 17:127-40. 10.1093\/glycob\/cwl067","journal-title":"Glycobiology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-0227","article-title":"Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats","volume":"44","author":"Akimoto Y","year":"2003","unstructured":"Akimoto Y, Kawakami H, Yamamoto K, Munetomo E, Hida T, Hirano H. Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats. Invest Ophthalmol Vis Sci. 2003, 44:3802-9. 10.1167\/iovs.03-0227","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0812","article-title":"Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance","volume":"145","author":"Hazel M","year":"2004","unstructured":"Hazel M, Cooksey RC, Jones D, et al.. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. Endocrinology. 2004, 145:2118-28. 10.1210\/en.2003-0812","journal-title":"Endocrinology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90281.2008","article-title":"Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity","volume":"295","author":"Copeland RJ","year":"2008","unstructured":"Copeland RJ, Bullen JW, Hart GW. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab. 2008, 295:E17-28. 10.1152\/ajpendo.90281.2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M500314-MCP200","article-title":"Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1","volume":"5","author":"Ball LE","year":"2006","unstructured":"Ball LE, Berkaw MN, Buse MG. Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. Mol Cell Proteomics. 2006, 5:313-23. 10.1074\/mcp.M500314-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2008.04.014","article-title":"O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells","volume":"314","author":"Kang ES","year":"2008","unstructured":"Kang ES, Han D, Park J, et al.. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells. Exp Cell Res. 2008, 314:2238-48. 10.1016\/j.yexcr.2008.04.014","journal-title":"Exp Cell Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M802240200","article-title":"O-GlcNAc regulates FoxO activation in response to glucose","volume":"283","author":"Housley MP","year":"2008","unstructured":"Housley MP, Rodgers JT, Udeshi ND, et al.. O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem. 2008, 283:16283-92. 10.1074\/jbc.M802240200","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(02)03774-2","article-title":"Glucosamine-induced insulin resistance is coupled to O-linked glycosylation of Munc18c","volume":"534","author":"Chen G","year":"2003","unstructured":"Chen G, Liu P, Thurmond DC, Elmendorf JS. Glucosamine-induced insulin resistance is coupled to O-linked glycosylation of Munc18c. FEBS Lett. 2003, 534:54-60. 10.1016\/S0014-5793(02)03774-2","journal-title":"FEBS Lett"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129190","article-title":"What lipodystrophies teach us about the metabolic syndrome","volume":"129","author":"Mann JP","year":"2019","unstructured":"Mann JP, Savage DB. What lipodystrophies teach us about the metabolic syndrome. J Clin Invest. 2019, 129:4009-21. 10.1172\/JCI129190","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608537103","article-title":"Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men","volume":"103","author":"Petersen KF","year":"2006","unstructured":"Petersen KF, Dufour S, Feng J, et al.. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci U S A. 2006, 103:18273-7. 10.1073\/pnas.0608537103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.3.603","article-title":"Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes","volume":"54","author":"Petersen KF","year":"2005","unstructured":"Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 2005, 54:603-8. 10.2337\/diabetes.54.3.603","journal-title":"Diabetes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini E","year":"2009","unstructured":"Fabbrini E, Magkos F, Mohammed BS, et al.. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009, 106:15430-5. 10.1073\/pnas.0904944106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051123","article-title":"Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study","volume":"42","author":"Krssak M","year":"1999","unstructured":"Krssak M, Falk Petersen K, Dresner A, et al.. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 1999, 42:113-6. 10.1007\/s001250051123","journal-title":"Diabetologia"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel VT","year":"2004","unstructured":"Samuel VT, Liu ZX, Qu X, et al.. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem. 2004, 279:32345-53. 10.1074\/jbc.M313478200","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.121164498","article-title":"Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance","volume":"98","author":"Kim JK","year":"2001","unstructured":"Kim JK, Fillmore JJ, Chen Y, et al.. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A. 2001, 98:7522-7. 10.1073\/pnas.121164498","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2912","article-title":"Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia","volume":"102","author":"Merkel M","year":"1998","unstructured":"Merkel M, Weinstock PH, Chajek-Shaul T, Radner H, Yin B, Breslow JL, Goldberg IJ. Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia. J Clin Invest. 1998, 102:893-901. 10.1172\/JCI2912","journal-title":"J Clin Invest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1839","article-title":"Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues","volume":"58","author":"Wang H","year":"2009","unstructured":"Wang H, Knaub LA, Jensen DR, et al.. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes. 2009, 58:116-24. 10.2337\/db07-1839","journal-title":"Diabetes"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300143-JLR200","article-title":"CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice","volume":"44","author":"Goudriaan JR","year":"2003","unstructured":"Goudriaan JR, Dahlmans VE, Teusink B, et al.. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res. 2003, 44:2270-7. 10.1194\/jlr.M300143-JLR200","journal-title":"J Lipid Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200418917","article-title":"Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle","volume":"113","author":"Kim JK","year":"2004","unstructured":"Kim JK, Gimeno RE, Higashimori T, et al.. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Investig. 2004, 113:756-63. 10.1172\/JCI200418917","journal-title":"J Clin Investig"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M803510200","article-title":"Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia","volume":"283","author":"Doege H","year":"2008","unstructured":"Doege H, Grimm D, Falcon A, et al.. Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia. J Biol Chem. 2008, 283:22186-92. 10.1074\/jbc.M803510200","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00226.2010","article-title":"FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase","volume":"299","author":"Falcon A","year":"2010","unstructured":"Falcon A, Doege H, Fluitt A, Tsang B, Watson N, Kay MA, Stahl A. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. Am J Physiol Endocrinol Metab. 2010, 299:E384-93. 10.1152\/ajpendo.00226.2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400835","article-title":"Insulin receptor internalization: molecular mechanisms and physiopathological implications","volume":"37 Suppl 2","author":"Carpentier JL","year":"1994","unstructured":"Carpentier JL. Insulin receptor internalization: molecular mechanisms and physiopathological implications. Diabetologia. 1994, 37 Suppl 2:S117-24. 10.1007\/BF00400835","journal-title":"Diabetologia"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel VT","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012, 148:852-71. 10.1016\/j.cell.2012.02.017","journal-title":"Cell"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(17)44844-7","article-title":"1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo","volume":"265","author":"Turinsky J","year":"1990","unstructured":"Turinsky J, O\u2019Sullivan DM, Bayly BP. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem. 1990, 265:16880-5. 10.1016\/s0021-9258(17)44844-7","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-2913-1","article-title":"Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding","volume":"56","author":"Turner N","year":"2013","unstructured":"Turner N, Kowalski GM, Leslie SJ, et al.. Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia. 2013, 56:1638-48. 10.1007\/s00125-013-2913-1","journal-title":"Diabetologia"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.24.7797","article-title":"Phorbol esters modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells","volume":"81","author":"Takayama S","year":"1984","unstructured":"Takayama S, White MF, Lauris V, Kahn CR. Phorbol esters modulate insulin receptor phosphorylation and insulin action in cultured hepatoma cells. Proc Natl Acad Sci U S A. 1984, 81:7797-801. 10.1073\/pnas.81.24.7797","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1769","article-title":"Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes","volume":"57","author":"Schmitz-Peiffer C","year":"2008","unstructured":"Schmitz-Peiffer C, Biden TJ. Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes. Diabetes. 2008, 57:1774-83. 10.2337\/db07-1769","journal-title":"Diabetes"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(18)86935-6","article-title":"Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats","volume":"265","author":"Karasik A","year":"1990","unstructured":"Karasik A, Rothenberg PL, Yamada K, White MF, Kahn CR. Increased protein kinase C activity is linked to reduced insulin receptor autophosphorylation in liver of starved rats. J Biol Chem. 1990, 265:10226-31. 10.1016\/s0021-9258(18)86935-6","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.04.002","article-title":"A ceramide-centric view of insulin resistance","volume":"15","author":"Chavez JA","year":"2012","unstructured":"Chavez JA, Summers SA. A ceramide-centric view of insulin resistance. Cell Metab. 2012, 15:585-94. 10.1016\/j.cmet.2012.04.002","journal-title":"Cell Metab"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen PK","year":"2016","unstructured":"Luukkonen PK, Zhou Y, S\u00e4devirta S, et al.. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol. 2016, 64:1167-75. 10.1016\/j.jhep.2016.01.002","journal-title":"J Hepatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland WL","year":"2007","unstructured":"Holland WL, Brozinick JT, Wang LP, et al.. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 2007, 5:167-79. 10.1016\/j.cmet.2007.01.002","journal-title":"Cell Metab"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1293","article-title":"Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption","volume":"59","author":"Ussher JR","year":"2010","unstructured":"Ussher JR, Koves TR, Cadete VJ, et al.. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption. Diabetes. 2010, 59:2453-64. 10.2337\/db09-1293","journal-title":"Diabetes"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin SM","year":"2014","unstructured":"Turpin SM, Nicholls HT, Willmes DM, et al.. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab. 2014, 20:678-86. 10.1016\/j.cmet.2014.08.002","journal-title":"Cell Metab"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200525102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen KE","year":"2005","unstructured":"Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Investig. 2005, 115:1111-9. 10.1172\/JCI200525102","journal-title":"J Clin Investig"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0590-z","article-title":"Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes","volume":"50","author":"Laybutt DR","year":"2007","unstructured":"Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV, Biden TJ. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia. 2007, 50:752-63. 10.1007\/s00125-006-0590-z","journal-title":"Diabetologia"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0816-8","article-title":"The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients","volume":"50","author":"Marchetti P","year":"2007","unstructured":"Marchetti P, Bugliani M, Lupi R, et al.. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia. 2007, 50:2486-94. 10.1007\/s00125-007-0816-8","journal-title":"Diabetologia"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01708-8","article-title":"Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches","volume":"29","author":"Mahmoudi SK","year":"2024","unstructured":"Mahmoudi SK, Tarzemani S, Aghajanzadeh T, Kasravi M, Hatami B, Zali MR, Baghaei K. Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches. Eur J Med Res. 2024, 29:190. 10.1186\/s40001-024-01708-8","journal-title":"Eur J Med Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.21037\/tgh.2019.09.06","article-title":"Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)","volume":"6","author":"Choudhary NS","year":"2021","unstructured":"Choudhary NS, Duseja A. Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). Transl Gastroenterol Hepatol. 2021, 6:2. 10.21037\/tgh.2019.09.06","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114698","article-title":"Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature","volume":"193","author":"Kim S","year":"2021","unstructured":"Kim S, Choi S, Dutta M, et al.. Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signature. Biochem Pharmacol. 2021, 193:114698. 10.1016\/j.bcp.2021.114698","journal-title":"Biochem Pharmacol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6613827","article-title":"NAFLD, insulin resistance, and diabetes mellitus type 2","volume":"2021","author":"Maru\u0161i\u0107 M","year":"2021","unstructured":"Maru\u0161i\u0107 M, Pai\u0107 M, Knobloch M, Liberati Pr\u0161o AM. NAFLD, insulin resistance, and diabetes mellitus type 2. Can J Gastroenterol Hepatol. 2021, 2021:6613827. 10.1155\/2021\/6613827","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2015.02.018","article-title":"Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link?","volume":"418 Pt 1","author":"Asrih M","year":"2015","unstructured":"Asrih M, Jornayvaz FR. Metabolic syndrome and nonalcoholic fatty liver disease: is insulin resistance the link?. Mol Cell Endocrinol. 2015, 418 Pt 1:55-65. 10.1016\/j.mce.2015.02.018","journal-title":"Mol Cell Endocrinol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MAFLD","volume":"22","author":"Sakurai Y","year":"2021","unstructured":"Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of insulin resistance in MAFLD. Int J Mol Sci. 2021, 22:10.3390\/ijms22084156","journal-title":"Int J Mol Sci"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.152","article-title":"Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease","volume":"105","author":"Patton HM","year":"2010","unstructured":"Patton HM, Yates K, Unalp-Arida A, et al.. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol. 2010, 105:2093-102. 10.1038\/ajg.2010.152","journal-title":"Am J Gastroenterol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.36011\/cpp.2022.4.e17","article-title":"The crosstalk between insulin resistance and nonalcoholic fatty liver disease\/metabolic dysfunction-associated fatty liver disease: a culprit or a consequence?","volume":"4","author":"Koo D-J","year":"2022","unstructured":"Koo D-J, Lee W-Y. The crosstalk between insulin resistance and nonalcoholic fatty liver disease\/metabolic dysfunction-associated fatty liver disease: a culprit or a consequence?. Cardiovasc Prevent Pharmacother. 2022, 4:132-41. 10.36011\/cpp.2022.4.e17","journal-title":"Cardiovasc Prevent Pharmacother"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2021.04.003","article-title":"A PERKy way to make mitochondrial cristae","volume":"32","author":"Cannon B","year":"2021","unstructured":"Cannon B, Nedergaard J. A PERKy way to make mitochondrial cristae. Trends Endocrinol Metab. 2021, 32:417-9. 10.1016\/j.tem.2021.04.003","journal-title":"Trends Endocrinol Metab"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-017-0436-0","article-title":"New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Zhang X","year":"2018","unstructured":"Zhang X, Ji X, Wang Q, Li JZ. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein Cell. 2018, 9:164-77. 10.1007\/s13238-017-0436-0","journal-title":"Protein Cell"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone F","year":"2019","unstructured":"Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019, 76:99-128. 10.1007\/s00018-018-2947-0","journal-title":"Cell Mol Life Sci"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg H","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017, 14:32-42. 10.1038\/nrgastro.2016.147","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-079750","article-title":"Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review","volume":"14","author":"Moss K","year":"2024","unstructured":"Moss K, Gitman V, Pinto Sanchez MI, et al.. Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review. BMJ Open. 2024, 14:e079750. 10.1136\/bmjopen-2023-079750","journal-title":"BMJ Open"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111905","article-title":"Clinical and molecular biomarkers for diagnosis and staging of NAFLD","volume":"22","author":"Di Mauro S","year":"2021","unstructured":"Di Mauro S, Scamporrino A, Filippello A, et al.. Clinical and molecular biomarkers for diagnosis and staging of NAFLD. Int J Mol Sci. 2021, 22:10.3390\/ijms222111905","journal-title":"Int J Mol Sci"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i32.7236","article-title":"Transient elastography (FibroScan(\u00ae)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - where do we stand?","volume":"22","author":"Mikolasevic I","year":"2016","unstructured":"Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan(\u00ae)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - where do we stand?. World J Gastroenterol. 2016, 22:7236-51. 10.3748\/wjg.v22.i32.7236","journal-title":"World J Gastroenterol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/839275","article-title":"Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?","volume":"2013","author":"Hafeez S","year":"2013","unstructured":"Hafeez S, Ahmed MH. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?. J Obes. 2013, 2013:839275. 10.1155\/2013\/839275","journal-title":"J Obes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/320817-a-comprehensive-review-of-pathophysiological-link-between-non-alcoholic-fatty-liver-disease-insulin-resistance-and-metabolic-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T01:29:50Z","timestamp":1734139790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/320817-a-comprehensive-review-of-pathophysiological-link-between-non-alcoholic-fatty-liver-disease-insulin-resistance-and-metabolic-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":72,"URL":"https:\/\/doi.org\/10.7759\/cureus.75677","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}